Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells

Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells

US Patent 10117899 · Granted Nov 6, 2018

Estimated economic value: $22,445,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for improving retroviral transduction and gene editing in hematopoietic s2025
Method for improving retroviral transduction and gene editing in hematopoietic s2025
Compositions and methods for epigenetic regulation of HBV gene expression2025
Virus vector production2025
Systems and methods for treating hyper-igm syndrome2025
Systems and methods for treating hyper-igm syndrome2025
Permanent epigenetic gene silencing2024
Permanent epigenetic gene silencing2024
Method for improving retroviral transduction and gene editing in hematopoietic s2024
Method for improving retroviral transduction and gene editing in hematopoietic s2024
Vector production2024
Vector production2024